People living with interstitial lung disease (ILD) are especially vulnerable during extreme heat. As climate change drives more frequent and intense heatwaves, people with ILD will need better ...
Nintedanib offered no significant advantage over placebo in patients with interstitial lung disease (ILD) following a severe SARS-CoV-2 infection. No significant differences were observed between ...
Connective tissue diseases (CTDs) associated with interstitial lung disease (ILD) involve autoimmune disorders affecting the skin, joints, and lungs, leading to inflammation and fibrosis. Conditions ...
Despite the introduction of new therapies, connective tissue disease-associated interstitial lung disease (CTD-ILD) remains an area of significant unmet need, according to findings from the recently ...
Rheumatoid arthritis is associated with increased respiratory-related mortality in non-tuberculosis mycobacterial pulmonary ...
Alicia M. Hinze, MD: Some of the unmet needs that we have in interstitial lung disease [ILD] in the context of scleroderma would be, what do we do if patients continue to progress on our ...
Familial pulmonary fibrosis accounts for a considerable number of interstitial lung disease cases, a new study shows.
Diffuse parenchymal lung diseases encompass a large number of conditions, with a wide range of causes, clinical manifestations, and imaging and pathological features, as well as variable outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results